Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2026-02-10 @ 9:37 AM
Study NCT ID:
NCT03364868
Status:
COMPLETED
Last Update Posted:
2024-10-08
First Post:
2017-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)
Sponsor:
Technical University of Munich
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-13
First Submit QC Date:
None
Study First Post Date:
2017-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-04
Last Update Post Date:
2024-10-08
Last Update Post Date Type:
ACTUAL